Contact us now to get immediate help: 1-855-350-3330
Common club drugs are MDMA (ecstasy), Rohypnol, GHB, and ketamine. These drugs used by teens and young adults who are part of a nightclub, bar, rave, or trance scene. Raves and trance events are generally night-long dances, often held in warehouses. Many who attend raves and trances do not use club drugs, but those who do may be attracted to their generally low cost, and to the intoxicating highs that are said to deepen the rave or trance experience.
For the third and fourth quarters of 2003, hospital emergency department mentions were estimated at 2,221 for MDMA use, 990 for GHB, and 73 for ketamine.*
MDMA (3-4 methylenedioxymethamphetamine) is a synthetic, psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline. Street names for MDMA include "ecstasy," "XTC," and "hug drug." In high doses, MDMA can interfere with the body's ability to regulate temperature. On rare but unpredictable occasions, this can lead to a sharp increase in body temperature (hypothermia), resulting in liver, kidney, and cardiovascular system failure, and death. Because MDMA can interfere with its own metabolism (breakdown within the body), potentially harmful levels can be reached by repeated drug use within short intervals.
Research in animals links MDMA exposure to long-term damage to serotonin neurons. A study in nonhuman primates showed that exposure to MDMA for only 4 days caused damage of serotonin nerve terminals that was evident 6 to 7 years later. While similar neurotoxicity has not been definitively shown in humans, the wealth of animal research indicating MDMA’s damaging properties suggests that MDMA is not a safe drug for human consumption.
According to the Monitoring the Future** (MTF) survey, NIDA's annual survey of drug use and associated attitudes among the Nation's 8th-, 10th-, and 12th-graders, 12th-graders reported significant declines in lifetime*** MDMA use and perceived availability of the drug in 2005. Perceived harmfulness in occasional MDMA use declined significantly among 8th-graders, from 65.1 percent in 2004 to 60.8 percent in 2005.
Another national survey, the National Survey on Drug Use and Health,**** reported 450,000 current ecstasy users in 2004, which is similar to the number reported in 2003. Past year ecstasy use declined from 3.7 percent in 2003 to 3.1 percent in 2004 among young adults aged 18 to 25. Approximately 607,000 Americans used ecstasy for the first time in 2004. The majority of these new users were 18 or older, and the average age was 19.5 years.
GHB and Rohypnol are predominantly central nervous system depressants. Because they are often colorless, tasteless, and odorless, they can be added to beverages and ingested unknowingly.
These drugs emerged several years ago as "date rape" drugs.***** Because of concern about their abuse, Congress passed the "Drug-Induced Rape Prevention and Punishment Act of 1996" in October 1996. This legislation increased Federal penalties for use of any controlled substance to aid in sexual assault.
Coma and seizures can occur following use of GHB. Combining use with other drugs such as alcohol can result in nausea and breathing difficulties. GHB may also produce withdrawal effects, including insomnia, anxiety, tremors, and sweating. GHB and two of its precursors, gamma butyrolactone (GBL) and 1,4 butanediol (BD), have been involved in poisonings, overdoses, date rapes, and deaths.
Certain doses of ketamine can cause dream-like states and hallucinations. In high doses, ketamine can cause delirium, amnesia, impaired motor function, high blood pressure, depression, and potentially fatal respiratory problems.
Rohypnol is not approved for use in the United States, and its importation is banned. Illicit use of Rohypnol started appearing in the United States in the early 1990s, where it became known as "rophies," "roofies," "roach," and "rope."
Abuse of two other similar drugs appears to have replaced Rohypnol abuse in some regions of the country. These are clonazepam, marketed in the U.S. as Klonopin and in Mexico as Rivotril, and alprazolam, marketed as Xanax.
Find Top Treatment Facilities Near You
Speak with a Certified Treatment Assesment Counselor who can go over all your treatment options and help you find the right treatment program that fits your needs.
Discuss Treatment Options!
Our Counselors are available 24 hours a day, 7 days a week to discuss your treatment needs and help you find the right treatment solution.
© Copyright 1998 - 2017 All Rights Reserved. Content is protected under copyright laws, do not use content without written permission.